Search filters

List of works by Laura Pizzuti

"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome.

scientific article published on 18 February 2016

A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer.

scientific article published on 11 November 2016

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

scientific article

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

scientific article published on 25 May 2017

Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression. ⬇️

scientific article published on 14 August 2017

Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment.

scientific article published on 28 March 2016

Anthropometric, metabolic and molecular determinants of human epidermal growth factor receptor 2 expression in luminal B breast cancer

scientific article published in August 2015

Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.

scientific article published on 20 September 2014

Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerations.

scientific article published on 13 August 2014

Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin.

scientific article published on 9 October 2015

Body mass index and treatment outcomes following neoadjuvant therapy in women aged 45 y or younger: Evidence from a historic cohort

scientific article published on 02 March 2016

Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.

scientific article published on 16 January 2018

Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.

scientific article

Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer

scientific article published on 04 September 2018

DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis

scientific article

DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.

scientific article published on 24 February 2017

Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer

scientific article published on 22 July 2018

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

scientific article published on 07 August 2019

Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer.

scientific article

Emerging biological treatments for uterine cervical carcinoma.

scientific article published on 05 January 2014

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios

scientific article published on 12 October 2019

Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy.

scientific article published on 7 April 2017

Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy

scientific article published on 5 February 2018

FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort.

scientific article published on 17 September 2013

Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial.

scientific article published on 20 April 2017

GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer.

scientific article published on 20 May 2017

Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.

scientific article published on 08 August 2013

Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer: A case report

scientific article published on 01 September 2019

Hot flushes in women with breast cancer: state of the art and future perspectives

scientific article published on 06 December 2013

Immunologic treatments for precancerous lesions and uterine cervical cancer

scientific article published on 26 March 2014

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

scientific article published on 15 January 2020

Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.

scientific article published on 28 August 2013

Metabolic Determinants and Anthropometric Indicators Impact Clinical-pathological Features in Epithelial Ovarian Cancer Patients.

scientific article published on 10 February 2016

Metformin and breast cancer: basic knowledge in clinical context.

scientific article published on 17 March 2015

Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma

scientific article published on 16 July 2019

Neoadjuvant Chemotherapy In Triple-Negative Breast Cancer: A Multicentric Retrospective Observational Study In Real-Life Setting.

scientific article published on 15 July 2017

Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting.

scientific article

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

scientific article published on 10 December 2018

Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis

scientific article published on 17 October 2015

Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting

scientific article published on 18 August 2019

Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors

scientific article published on 03 June 2020

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy.

scientific article

The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications.

scientific article published on 02 July 2015

The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression

scientific article published on 24 April 2018

Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy

scientific article published on 2 April 2016

p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab.

scientific article

Paulina is supported by:

About Paulina

Help